These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8156973)

  • 21. The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites.
    Rouan MC; Lecaillon JB; Godbillon J; Menard F; Darragon T; Meyer P; Kourilsky O; Hillion D; Aldigier JC; Jungers P
    Eur J Clin Pharmacol; 1994; 47(2):161-7. PubMed ID: 7859804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergy to carbamazepine: parallel in vivo and in vitro detection.
    Troost RJ; Van Parys JA; Hooijkaas H; van Joost T; Benner R; Prens EP
    Epilepsia; 1996 Nov; 37(11):1093-9. PubMed ID: 8917060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oxcarbazepine in the treatment of epilepsy. A review and update].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Jan 16-31; 42(2):95-113. PubMed ID: 16450324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxcarbazepine.
    Tecoma ES
    Epilepsia; 1999; 40 Suppl 5():S37-46. PubMed ID: 10530693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical aspects of oxcarbazepine treatment.
    Dam M
    Epilepsia; 1994; 35 Suppl 3():S23-5. PubMed ID: 8156977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Removal of 10-hydroxycarbazepine by plasmapheresis.
    Christensen J; Balslev T; Villadsen J; Heinsvig EM; Dam M; Poulsen JH
    Ther Drug Monit; 2001 Aug; 23(4):374-9. PubMed ID: 11477319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxcarbazepine does not affect the anticoagulant activity of warfarin.
    Krämer G; Tettenborn B; Klosterskov Jensen P; Menge GP; Stoll KD
    Epilepsia; 1992; 33(6):1145-8. PubMed ID: 1464277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability.
    Hellewell JS
    J Affect Disord; 2002 Dec; 72 Suppl 1():S23-34. PubMed ID: 12589900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetic analysis for 10-monohydroxy derivative of oxcarbazepine in pediatric epileptic patients shows no difference between Japanese and other ethnicities.
    Sugiyama I; Bouillon T; Yamaguchi M; Suzuki H; Hirota T; Fink M
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):160-7. PubMed ID: 25989891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.
    Lin WW; Li XW; Jiao Z; Zhang J; Rao X; Zeng DY; Lin XH; Wang CL
    Eur J Clin Pharmacol; 2019 Mar; 75(3):381-392. PubMed ID: 30456415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects.
    Larkin JG; McKee PJ; Forrest G; Beastall GH; Park BK; Lowrie JI; Lloyd P; Brodie MJ
    Br J Clin Pharmacol; 1991 Jan; 31(1):65-71. PubMed ID: 2015172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does oxcarbazepine warrant therapeutic drug monitoring? A critical review.
    Bring P; Ensom MH
    Clin Pharmacokinet; 2008; 47(12):767-78. PubMed ID: 19026033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects.
    Antunes NJ; van Dijkman SC; Lanchote VL; Wichert-Ana L; Coelho EB; Alexandre Junior V; Takayanagui OM; Tozatto E; van Hasselt JGC; Della Pasqua O
    Eur J Pharm Sci; 2017 Nov; 109S():S116-S123. PubMed ID: 28528287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy.
    Yu Y; Zhang Q; Xu W; Lv C; Hao G
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):345-51. PubMed ID: 25700977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis.
    Luszczki JJ; Borowicz KK; Swiader M; Czuczwar SJ
    Epilepsia; 2003 Apr; 44(4):489-99. PubMed ID: 12680997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine.
    Isojärvi JI; Airaksinen KE; Mustonen JN; Pakarinen AJ; Rautio A; Pelkonen O; Myllylä VV
    Epilepsia; 1995 Aug; 36(8):810-6. PubMed ID: 7635100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on cyp3a4.
    Andreasen AH; Brøsen K; Damkier P
    Epilepsia; 2007 Mar; 48(3):490-6. PubMed ID: 17346248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
    Schmidt D; Elger CE
    Epilepsy Behav; 2004 Oct; 5(5):627-35. PubMed ID: 15380112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension.
    Clemens PL; Cloyd JC; Kriel RL; Remmel RP
    Clin Drug Investig; 2007; 27(4):243-50. PubMed ID: 17358096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.